# Bendamustine Hydrochloride

NDC: 60505-6228
Generic name: Bendamustine Hydrochloride
Labeler / Manufacturer: Apotex Corp
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230426

FDA application: NDA215033

## Active ingredients

- BENDAMUSTINE HYDROCHLORIDE: 25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60505-6228"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60505-6228
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=085dd54c-4212-d879-afef-ee52732a48c0